Matches in Nanopublications for { ?s ?p "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP120182.RAnTx0Y6ixyui3Y4Mx1f_JbuVtIwoHxCG50lUf8tUl4eA130_assertion description "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120182.RAnTx0Y6ixyui3Y4Mx1f_JbuVtIwoHxCG50lUf8tUl4eA130_provenance.
- NP104113.RAjkCQYslIHsS3hahmm4orI5rcR81UNGmAQp1mnQ-ehs0130_assertion description "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP104113.RAjkCQYslIHsS3hahmm4orI5rcR81UNGmAQp1mnQ-ehs0130_provenance.
- assertion description "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP221132.RAbEecw2QUQbvpmdH-9N9YTwQ8YST0_-aP8XUXRX8Ihr4130_assertion description "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221132.RAbEecw2QUQbvpmdH-9N9YTwQ8YST0_-aP8XUXRX8Ihr4130_provenance.
- NP183375.RA6X-hBP7VeTi5Rm9M6Cr9bD91no1MUZB2fyV6BE9TYYA130_assertion description "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183375.RA6X-hBP7VeTi5Rm9M6Cr9bD91no1MUZB2fyV6BE9TYYA130_provenance.
- NP167333.RAPlNzDL-q-TWEgaL5GoWwlBIl-_DMGmorsXZ8ij6rZzM130_assertion description "[PcG protein BMI1 is associated with adverse pathological features and clinical PSA recurrence of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167333.RAPlNzDL-q-TWEgaL5GoWwlBIl-_DMGmorsXZ8ij6rZzM130_provenance.